Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
Rezafungin is a novel echinocandin drug being developed as a first-line option for treatment and prevention of invasive fungal infections. As a result of a structural modification in its parent molecule anidulafungin, rezafungin has acquired unique chemical stability conferring prolonged pharmacokin...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2020-09-01
|
| Serija: | Journal of Fungi |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2309-608X/6/4/192 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|